Tourmaline Bio, Inc. (TRML) Stock Analysis

DELISTED 2025

What happened to Tourmaline Bio, Inc. (TRML) stock?

Tourmaline Bio, Inc. (TRML) no longer trades on public markets. It was delisted in October 2025. The figures below are historical and are not a current quote.

Status:: Delisted — no longer trades
Delisting date:: October 2025
Last recorded price (historical):: $47.98 (last quote on record before the October 2025 delisting; historical, not a current quote)

MCap: $1.23B| Vol: 783.7K| Target: $48.50 (Stored FMP targets · Captured Aug 25, 2026 · Capture expired) (estimate, not advice)| 52-wk range: $11.56 – $48.27

Market cap $1.23B is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Tourmaline Bio, Inc. (TRML). Tourmaline Bio, Inc. is a clinical-stage biotechnology company focused on developing treatments for life-altering immune diseases. Their pipeline targets conditions such as Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED).

Last analyzed: Mar 18, 2026

Tourmaline Bio, Inc. is a clinical-stage biotechnology company focused on developing treatments for life-altering immune diseases. Their pipeline targets conditions such as Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED).

Dated analysis: the newest financial statements on file are 25 months old (Sep 1, 2024), so the figures and score below describe that period, not today.

Tourmaline Bio, Inc. (TRML) Healthcare & Pipeline Overview

Employees74

IndustryBiotechnology

SectorHealthcare

Model self-rating on this text: 72% (not a measure of the evidence) Updated: Mar 18, 2026

More about this archive record

Can I still buy TRML shares?

No. TRML stopped trading on public markets in October 2025, so the shares are not available through a broker. Anything you see quoted for TRML elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before TRML stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Tourmaline Bio, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated Mar 18, 2026

Data Sources & Methodology

Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: Mar 18, 2026.

Data provided for informational purposes only.